Tilianin Protects against Nonalcoholic Fatty Liver Disease in Early Obesity Mice

Acacetin Protects against Non-Alcoholic Fatty Liver Disease by Regulating Lipid Accumulation and Inflammation in Mice

(2022) Chian-Jiun Liou et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Blueberry-derived exosomes-like nanoparticles ameliorate nonalcoholic fatty liver disease by attenuating mitochondrial oxidative stress

(2021) Wan-jun Zhao et al.   ACTA PHARMACOLOGICA SINICA

Shortening of membrane lipid acyl chains compensates for phosphatidylcholine deficiency in choline‐auxotroph yeast

(2021) Xue Bao et al.   EMBO JOURNAL

Synergistic cardioptotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4/NF-κB/NLRP3 and PGC1a/SIRT3 pathways

(2021) Jianping Yao et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Childhood obesity: a growing pandemic

(2021) The Lancet Diabetes & Endocrinology   Lancet Diabetes & Endocrinology

Prevention and Management of Childhood Obesity and Its Psychological and Health Comorbidities

(2020) Justin D. Smith et al.   Annual Review of Clinical Psychology

Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease

(2020) Ze Chen et al.   FREE RADICAL BIOLOGY AND MEDICINE

Herbal Combinational Medication of Glycyrrhiza glabra, Agastache rugosa Containing Glycyrrhizic Acid, Tilianin Inhibits Neutrophilic Lung Inflammation by Affecting CXCL2, Interleukin-17/STAT3 Signal Pathways in a Murine Model of COPD

(2020) Seung-Hyung Kim et al.   Nutrients

Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p/CPT1B axis

(2020) Yanqi Dang et al.   BIOMEDICINE & PHARMACOTHERAPY

Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis

(2020) Susanne Gaul et al.   JOURNAL OF HEPATOLOGY

Involvement of the Autophagy-ER Stress Axis in High Fat/Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease

(2020) Xiu Zhou et al.   Nutrients

Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes

(2019) Zhen Qiu et al.   Journal of Diabetes Research

Pretreatment with Tilianin improves mitochondrial energy metabolism and oxidative stress in rats with myocardial ischemia/reperfusion injury via AMPK/SIRT1/PGC-1 alpha signaling pathway

(2019) Li Tian et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation

(2019) Parvin Farzanegi et al.   European Journal of Sport Science

Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation

(2019) Jinchunzi Yang et al.   Nutrients

Cranberry Attenuates Progression of Non-alcoholic Fatty Liver Disease Induced by High-Fat Diet in Mice

(2019) Kahori Shimizu et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease

(2019) Huanbing Zhu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Improvement Effects of Trehangelin A on High-Fat Diet Causing Metabolic Clinical Conditions

(2019) Hiroki Ishikawa et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Newborn and childhood differential DNA methylation and liver fat in school-age children

(2019) Madelon L. Geurtsen et al.   Clinical Epigenetics

Targeting the NLRP3 inflammasome in inflammatory diseases

(2018) Matthew S. J. Mangan et al.   NATURE REVIEWS DRUG DISCOVERY

Ginsenoside Rg1 protects against non-alcoholic fatty liver disease by ameliorating lipid peroxidation, endoplasmic reticulum stress, and inflammasome activation

(2018) Yashu Xu et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

The biological and pharmacological roles of polyphenol flavonoid tilianin

(2018) Md Rashedunnabi Akanda et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Epidemic obesity in children and adolescents: risk factors and prevention

(2018) Eun Young Lee et al.   Frontiers of Medicine

NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice

(2017) Auvro R. Mridha et al.   JOURNAL OF HEPATOLOGY

Tilianin Post-Conditioning Attenuates Myocardial Ischemia/Reperfusion Injury via Mitochondrial Protection and Inhibition of Apoptosis

(2017) Yangyang Wang et al.   MEDICAL SCIENCE MONITOR

Antidiabetic, antihyperlipidemic and anti-inflammatory effects of tilianin in streptozotocin-nicotinamide diabetic rats

(2016) Jorge Alberto García-Díaz et al.   BIOMEDICINE & PHARMACOTHERAPY

Innate Immunity and Inflammation in NAFLD/NASH

(2016) Marco Arrese et al.   DIGESTIVE DISEASES AND SCIENCES

Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH

(2016) Xingyong Wan et al.   Canadian Journal of Gastroenterology and Hepatology

The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease

(2015) Huiting Gao et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Expression of Liver X Receptor Correlates with Intrahepatic Inflammation and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease

(2014) Sang Bong Ahn et al.   DIGESTIVE DISEASES AND SCIENCES

Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)?

(2014) Zoon Tariq et al.   LIVER INTERNATIONAL

High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis

(2010) Rohit Kohli et al.   HEPATOLOGY

Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease

(2008) Nobito Higuchi et al.   HEPATOLOGY RESEARCH